Successful In Situ Targeting of Pancreatic Tumors in a Novel Orthotopic Porcine Model Using Histotripsy.
Successful In Situ Targeting of Pancreatic Tumors in a Novel Orthotopic Porcine Model Using Histotripsy.
复制标题
DOI:
10.1016/j.ultrasmedbio.2023.07.013
复制
发表时间:
2023-11
影响因子:
2.9
通讯作者:
Allen, Irving C.
中科院分区:
文献类型:
--
作者:
Imran, Khan Mohammad;Gannon, Jessica;Morrison, Holly A.;Tupik, Juselyn D.;Tintera, Benjamin;Nagai-Singer, Margaret A.;Ivester, Hannah;Madanick, Justin Markov;Hendricks-Wenger, Alissa;Uh, Kyungjun;Luyimbazi, David T.;Edwards, Michael;Coutermarsh-Ott, Sheryl;Eden, Kristin;Byron, Christopher;Clark-Deener, Sherrie;Lee, Kiho;Vlaisavljevich, Eli;Allen, Irving C.
关键词:
New therapeutic strategies and paradigms are direly needed to treat pancreatic cancer. The absence of a suitable pre-clinical animal model of pancreatic cancer is a major limitation to biomedical device and therapeutic development. Traditionally, pigs have proven to be ideal models, especially in the context of designing human-sized instruments, perfecting surgical techniques and optimizing clinical procedures for use in humans. However, pig studies have typically focused on healthy tissue assessments and are limited to general safety evaluations because of the inability to effectively model human tumors. Here, we establish an orthotopic porcine model of human pancreatic cancer using RAG2/IL2RG double-knockout immunocompromised pigs and treat the tumors ex vivo and in vivo with histotripsy. Using these animals, we describe the successful engraftment of Panc-1 human pancreatic cancer cell line tumors and characterize their development. To illustrate the utility of these animals for therapeutic development, we determine for the first time, the successful targeting of in situ pancreatic tumors using histotripsy. Treatment with histotripsy resulted in partial ablation in vivo and reduction in collagen content in both in vivo tumor in pig pancreas and ex vivo patient tumor. This study presents a first step toward establishing histotripsy as a non-invasive treatment method for pancreatic cancer and exposes some of the challenges of ultrasound guidance for histotripsy ablation in the pancreas. Simultaneously, we introduce a highly robust model of pancreatic cancer in a large mammal model that could be used to evaluate a variety biomedical devices and therapeutic strategies.
登录
查看更多内容
影响因子:
4.6
作者:
Hendricks-Wenger A;Aycock KN;Nagai-Singer MA;Coutermarsh-Ott S;Lorenzo MF;Gannon J;Uh K;Farrell K;Beitel-White N;Brock RM;Simon A;Morrison HA;Tuohy J;Clark-Deener S;Vlaisavljevich E;Davalos RV;Lee K;Allen IC
通讯作者:
Allen IC
影响因子:
2.9
作者:
Arnold L;Hendricks-Wenger A;Coutermarsh-Ott S;Gannon J;Hay AN;Dervisis N;Klahn S;Allen IC;Tuohy J;Vlaisavljevich E
通讯作者:
Vlaisavljevich E
DOI:
10.1109/tuffc.2021.3110083
发表时间:
2022-01
期刊:
IEEE transactions on ultrasonics, ferroelectrics, and frequency control
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.4
作者:
Manresa, Mario C.;Miki, Haruka;Croft, Michae
通讯作者:
Croft, Michae
影响因子:
4.6
作者:
Bailey KL;Cartwright SB;Patel NS;Remmers N;Lazenby AJ;Hollingsworth MA;Carlson MA
通讯作者:
Carlson MA